Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS is working with advisors on strategic review, sources say
07:59pm, Monday, 30'th Sep 2024
CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter. The review has been ongoing for some time, said the people, but the
CVS is reportedly reviewing its options — including a possible breakup
07:43pm, Monday, 30'th Sep 2024
Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.
Exclusive: CVS explores options including potential break-up, sources say
07:02pm, Monday, 30'th Sep 2024
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes
CVS Health: Glenview's Activism Ramps Up Pressure On Management
05:23pm, Monday, 30'th Sep 2024
CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny, w
Stock Of The Day: Is It Time To Sell CVS?
04:33pm, Monday, 30'th Sep 2024
“Sell at former peaks” is an old Wall Street expression. People say this because stocks tend to run into resistance when they rally to a price level that has been a peak.
3-Stock Lunch: Nvidia, Carnival & CVS Health
03:33pm, Monday, 30'th Sep 2024
Michael Farr, Hightower Advisors chief market strategist, joins 'Power Lunch' to discuss stock plays for three stocks.
CVS Cuts 2900 Jobs Amid Hedge Fund Pressure
03:01pm, Monday, 30'th Sep 2024
CVS Health is reportedly meeting with a top investor on ways to enhance its business. The pharmacy/healthcare chain was set to meet Monday (Sept.
CVS Health Stock Gains on Report of Planned Meeting With Glenview Capital
02:50pm, Monday, 30'th Sep 2024
CVS Health (CVS) shares rose Monday on a report that major investor hedge fund Glenview Capital Management was planning to hold a meeting today with executives of the pharmacy and health care firm abo
Hedge fund mogul Larry Robbins seeks overhaul at struggling CVS: report
01:32pm, Monday, 30'th Sep 2024
Hedge fund mogul Larry Robbins will meet with executives at struggling drugstore chain CVS on Monday to present a turnaround plan that the Glenview Capital founder hopes will improve the firm's operat
CVS's stock rises nearly 3% on report of meeting with large hedge fund Glenview Capital
10:25am, Monday, 30'th Sep 2024
Gathering signals potential changes to improve shareholder value after the company's weak stock performance.
CVS Stock Is Rising. An Activist Wants Changes.
08:55am, Monday, 30'th Sep 2024
Glenview Capital Management will meet with top CVS executives to exchange ideas on how to make improvements at the healthcare company, according to a report from The Wall Street Journal.
Major CVS shareholder plans activist push, will meet with management, sources say
08:09pm, Sunday, 29'th Sep 2024
Glenview Capital has amassed a sizable stake in CVS Health and plans to meet with the company's top executives to lay out its plan for value creation, according to people familiar with the matter. The
Glenview Capital Plans Push for Changes at CVS
07:34pm, Sunday, 29'th Sep 2024
The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date
Glenview plans activist stance in push for changes at CVS, WSJ reports
07:27pm, Sunday, 29'th Sep 2024
Healthcare-focused Glenview Capital Management has established a large position in CVS Health and will meet top executives at the struggling healthcare company on Monday to propose ways it can improve
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
10:05am, Friday, 27'th Sep 2024
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
